Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant
Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…
Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid
Aurobindo Pharma announced that it has received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per ml. The…
Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session
Glenmark Pharmaceuticals Ltd is quoting at Rs 1979, up 0.2% on the day as on 12:44 IST on the NSE. The stock is up 27.57% in last one year as…
Glenmark Pharma launches TEVIMBRA in India
Glenmark Pharmaceuticals announced that it had launched TEVIMBRA (tislelizumab) in India after receiving approval from the Central Drugs Standard Control Organization (CDSCO). The drug is a specially designed anti-PD-1 monoclonal…
Alembic Pharma receives USFDA final approval for Pantoprazole Sodium Injection
Alembic Pharmaceuticals (Alembic) announced that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Pantoprazole Sodium. The approved…
SMS Pharma gains after Hyderabad facility completes USFDA inspection
SMS Pharmaceuticals rose 1.79% to Rs 221.80 after company announced that it has successfully completed a US Food and Drug Administration (USFDA) inspection at its API manufacturing facility located in…
